BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23059796)

  • 1. Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats.
    Sari Y; Sreemantula SN
    Neuroscience; 2012 Dec; 227():327-35. PubMed ID: 23059796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats.
    Sari Y; Sakai M; Weedman JM; Rebec GV; Bell RL
    Alcohol Alcohol; 2011; 46(3):239-46. PubMed ID: 21422004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats.
    Sari Y; Sreemantula SN; Lee MR; Choi DS
    J Mol Neurosci; 2013 Nov; 51(3):779-87. PubMed ID: 23893122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.
    Rao PS; Goodwani S; Bell RL; Wei Y; Boddu SH; Sari Y
    Neuroscience; 2015 Jun; 295():164-74. PubMed ID: 25813713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol.
    Rao PS; Saternos H; Goodwani S; Sari Y
    Psychopharmacology (Berl); 2015 Jul; 232(13):2333-42. PubMed ID: 25619881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats.
    Qrunfleh AM; Alazizi A; Sari Y
    J Psychopharmacol; 2013 Jun; 27(6):541-9. PubMed ID: 23518814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.
    Alhaddad H; Das SC; Sari Y
    Psychopharmacology (Berl); 2014 Oct; 231(20):4049-57. PubMed ID: 24687412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
    Das SC; Yamamoto BK; Hristov AM; Sari Y
    Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.
    Goodwani S; Rao PS; Bell RL; Sari Y
    Brain Res; 2015 Oct; 1622():397-408. PubMed ID: 26168897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake.
    Besheer J; Grondin JJ; Cannady R; Sharko AC; Faccidomo S; Hodge CW
    Biol Psychiatry; 2010 May; 67(9):812-22. PubMed ID: 19897175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats.
    Alhaddad H; Kim NT; Aal-Aaboda M; Althobaiti YS; Leighton J; Boddu SH; Wei Y; Sari Y
    Front Behav Neurosci; 2014; 8():366. PubMed ID: 25400560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone reduces alcohol intake in outbred rats while upregulating xCT in the nucleus accumbens core.
    Stennett BA; Frankowski JC; Peris J; Knackstedt LA
    Pharmacol Biochem Behav; 2017 Aug; 159():18-23. PubMed ID: 28687200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.
    Hakami AY; Sari Y
    Neurosci Lett; 2017 Sep; 657():140-145. PubMed ID: 28826758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats.
    Aal-Aaboda M; Alhaddad H; Osowik F; Nauli SM; Sari Y
    J Neurosci Res; 2015 Jun; 93(6):930-7. PubMed ID: 25601490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats.
    Rao PS; Sari Y
    J Mol Neurosci; 2014 Sep; 54(1):71-7. PubMed ID: 24535561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.
    Sabino V; Cottone P; Zhao Y; Steardo L; Koob GF; Zorrilla EP
    Psychopharmacology (Berl); 2009 Aug; 205(2):327-35. PubMed ID: 19440699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cefazolin and cefoperazone on glutamate transporter 1 isoforms and cystine/glutamate exchanger as well as alcohol drinking behavior in male alcohol-preferring rats.
    Alasmari F; Rao PSS; Sari Y
    Brain Res; 2016 Mar; 1634():150-157. PubMed ID: 26790351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated cocaine exposure and withdrawal on voluntary ethanol drinking, and the expression of glial glutamate transporters in mesocorticolimbic system of P rats.
    Hammad AM; Althobaiti YS; Das SC; Sari Y
    Mol Cell Neurosci; 2017 Jul; 82():58-65. PubMed ID: 28442364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of novel GLT-1 modulator, MC-100093, on neuroinflammatory and neurotrophic biomarkers in mesocorticolimbic brain regions of male alcohol preferring rats exposed chronically to ethanol.
    Travaglianti S; Alotaibi A; Wong W; Abou-Gharbia M; Childers W; Sari Y
    Brain Res Bull; 2024 Jun; 211():110935. PubMed ID: 38570076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of orally administered Augmentin on glutamate transporter 1, cystine-glutamate exchanger expression and ethanol intake in alcohol-preferring rats.
    Hakami AY; Alshehri FS; Althobaiti YS; Sari Y
    Behav Brain Res; 2017 Mar; 320():316-322. PubMed ID: 27993695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.